ImmuCell Corporation Amortization of Debt Issuance Costs and Discounts
ImmuCell Corporation (ICCC) reported Amortization of Debt Issuance Costs and Discounts of $3.16 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-13
- ImmuCell Corporation amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $3.16K, a 70.78% decline year-over-year.
- ImmuCell Corporation amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $3.16K, a 70.78% decline year-over-year.
- ImmuCell Corporation amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $3.16K, a 70.79% decline year-over-year.
- ImmuCell Corporation amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $29.58K, a 173.74% increase year-over-year.
- ImmuCell Corporation amortization of debt issuance costs and discounts for fiscal 2025 was $54.35K, a 27.38% increase from fiscal 2024.
- ImmuCell Corporation amortization of debt issuance costs and discounts for fiscal 2024 was $42.67K, a 88.63% increase from fiscal 2023.
- ImmuCell Corporation amortization of debt issuance costs and discounts for fiscal 2023 was $22.62K, a 195.36% increase from fiscal 2022.
- ImmuCell Corporation amortization of debt issuance costs and discounts for fiscal 2022 was $7.66K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.16K 10-Q · filed 2026-08-13 | $6.32K 10-Q · filed 2026-08-13 | $9.47K derived: sum of 3 quarters · filed 2026-08-13 | $39.05K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $3.16K 10-Q · filed 2026-05-14 | $6.32K derived: sum of 2 quarters · filed 2026-05-14 | $35.89K derived: sum of 3 quarters · filed 2026-05-14 | $46.70K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $32.73K derived: sum of 2 quarters · filed 2026-03-30 | $43.54K derived: sum of 3 quarters · filed 2026-08-13 | $54.35K 10-K · filed 2026-03-30 |
| 2025-09-30 | $29.58K 10-Q · filed 2025-11-13 | $40.38K derived: sum of 2 quarters · filed 2026-08-13 | $51.19K 10-Q · filed 2025-11-13 | $62.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $10.81K 10-Q · filed 2026-08-13 | $21.61K 10-Q · filed 2026-08-13 | $32.42K derived: sum of 3 quarters · filed 2026-08-13 | $43.22K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $10.81K 10-Q · filed 2026-05-14 | $21.61K derived: sum of 2 quarters · filed 2026-05-14 | $32.42K derived: sum of 3 quarters · filed 2026-05-14 | $43.22K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $10.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $21.61K derived: sum of 2 quarters · filed 2026-03-30 | $32.42K derived: sum of 3 quarters · filed 2026-03-30 | $42.67K 10-K · filed 2026-03-30 |
| 2024-09-30 | $10.80K 10-Q · filed 2025-11-13 | $21.61K derived: sum of 2 quarters · filed 2025-11-13 | $31.86K 10-Q · filed 2025-11-13 | $41.95K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $10.81K 10-Q · filed 2025-08-14 | $21.05K 10-Q · filed 2025-08-14 | $31.15K derived: sum of 3 quarters · filed 2025-08-14 | $39.83K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $10.25K 10-Q · filed 2025-05-14 | $20.34K derived: sum of 2 quarters · filed 2025-05-14 | $29.03K derived: sum of 3 quarters · filed 2025-05-14 | $30.95K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $10.09K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $18.78K derived: sum of 2 quarters · filed 2025-03-28 | $20.70K derived: sum of 3 quarters · filed 2025-03-28 | $22.62K 10-K · filed 2025-03-28 |
| 2023-09-30 | $8.69K 10-Q · filed 2024-11-13 | $10.61K derived: sum of 2 quarters · filed 2024-11-13 | $12.53K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $1.92K 10-Q · filed 2024-08-13 | $3.84K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $1.92K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $7.66K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |